homa-ad in assessing insulin resistance in lean noncirrhotic hcv outpatients
Clicks: 149
ID: 234379
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
149 views
29 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #17 of 25 articles by views in harbin gongye daxue xuebao/journal of harbin institute of technology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Introduction. There is an association between HCV and insulin resistance (IR), which is currently assessed by HOMA-IR. There is evidence that HOMA-adiponectin (HOMA-AD) is more accurate, but its role in HCV patients is unknown. The purpose of this study was to evaluate IR in an HCV sample and controls, in order to compare the accuracy of HOMA-IR and HOMA-AD. Methods. Ninety-four HCV outpatients aged <60 years who met the criteria of nondiabetic, nonobese, noncirrhotic, and nonalcohol abusers were included and compared to 29 controls. Fasting glucose, insulin, adiponectin, and lipid profiles were determined. IR was estimated by HOMA-IR and HOMA-AD. Results. The groups were similar regarding sex and BMI, but the HCV patients were older. The median insulin level was higher in the HCV group (8.6 mU/mL (6.5–13.7) versus 6.5 (4.3–10.7), P=0.004), as was median HOMA-IR (1.94 (1.51 to 3.48) versus 1.40 (1.02 to 2.36), P=0.002) and the prevalence of IR (38.3% versus 10.3% (P=0.009)). No differences were found in adiponectin levels (P=0.294) and HOMA-AD (P=0.393). Conclusion. IR is highly prevalent even in low-risk HCV outpatients. Adiponectin is not influenced by the presence of HCV. HOMA-AD does not seem to be useful in assessing IR in HCV patients.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (64 words).
Try re-searching for a better abstract.
| Reference Key |
michalczuk2012internationalhoma-ad
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Matheus Truccolo Michalczuk;Camila Rippol Kappel;Oscar Birkhan;Ana Carolina Bragança;Mário Reis Álvares-da-Silva |
| Journal | harbin gongye daxue xuebao/journal of harbin institute of technology |
| Year | 2012 |
| DOI |
10.1155/2012/576584
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.